金屬硫蛋白1(MT1)多克隆抗體
Polyclonal Antibody to Metallothionein 1 (MT1)
MT1A; MT1S; MTC
- 編號UPAB119Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPB119Hu01-金屬硫蛋白1(MT1)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度0.5mg/mL
- 且適物種-
- 應(yīng)用IHC
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 299 ¥ 697 ¥ 996 ¥ 2490 ¥ 9960
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Samples: Human Colon Tissue; Primary Ab: 20μg/ml Rabbit Anti-Human MT1 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant MT1, Human.
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對MT1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別MT1。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| UEPB119Hu61 | 金屬硫蛋白1(MT1)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPB119Hu01 | 金屬硫蛋白1(MT1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAB119Hu01 | 金屬硫蛋白1(MT1)多克隆抗體 | IHC |
| UMAB119Hu22 | 金屬硫蛋白1(MT1)單克隆抗體 | WB; IHC; ICC; IP. |
| USEB119Hu | 金屬硫蛋白1(MT1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMB119Hu | 金屬硫蛋白1(MT1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Biotechology letters | Modulated expression of genes associated with NO signal transduction contributes to the cholesterol-lowering effect of electro-acupuncture [SpringerLink: c1v4234150886817] |
| International Journal of Diabetes in Developing Countries | Evaluation of serum metallothionein-1, selenium, zinc, and copper in Ghanaian type 2 diabetes mellitus patients [Springer: Source] |
| Experimental Oncology | Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin [Pubmed:25265354] |
| Journal of Neurochemistry | Neuroprotective?effects?of?levetiracetam?target?xCT?in?astrocytes?in?parkinsonian?mice. [Pubmed:26485447] |
| Toxicology Mechanisms and Methods | Evaluation of hepatorenal impairments in Wistar rats coexposed to low-dose lead, cadmium and manganese: insights into oxidative stress mechanism [pubmed:27599793] |
| Environmental toxicology and pharmacology | Dyslipdemia induced by chronic low dose co-exposure to lead, cadmium and manganese in rats: the role of oxidative stress [pubmed:28654832] |
| European?Journal?of?Immunology | Metallothionein‐1 suppresses rheumatoid arthritis pathogenesis by shifting the Th17/Treg balance [Pubmed:30055006] |
| Int Immunopharmacol | Metallothionein-1 is associated with osteoarthritis disease activity and suppresses proinflammatory cytokines production in synovial cells [Pubmed: 31465913] |
| Influence of cadmium on blood and hair trace elements and biochemical markers [] |
留言咨詢
